O-2545 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. Unlike most cannabinoids discovered to date it is water soluble which gives it considerable advantages over many related cannabinoids. It has high affinity for both CB1 and CB2 receptors with Ki values of 1.5nM at CB1 and 0.32nM at CB2.
This page contains content from the copyrighted Wikipedia article "O-2545"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
